Tepper, Stewart J.
Cirillo, Jessica
Kim, Edward
L’Italien, Gil
Tweedie, Julie M.
Lodaya, Kunal
Riley, Dushon
Pathan, Farah
Antaki, Nicholas
Nathanson, Brian H.
McAllister, Peter
Funding for this research was provided by:
Biohaven Pharmaceuticals
Article History
Received: 9 January 2023
Accepted: 26 April 2023
First Online: 16 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: S. J. Tepper reports grants for research (no personal compensation) from Allergan/Abbvie, Amgen, Eli Lilly, Lundbeck, Neurolief, Novartis, Satsuma, and Zosano; consultant and/or advisory Boards (honoraria) from Aeon, Allergan/Abbvie, Alphasights, Amgen, Aruene, Atheneum, Axsome Therapeutics, Becker Pharmaceutical Consulting, BioDelivery Sciences International, Biohaven, ClearView Healthcare Partners, CoolTech, CRG, Currax, Decision Resources, Defined Health, DRG, Eli Lilly, ExpertConnect, FCB Health, Fenix, GLG, Guidepoint Global, Health Advances, Health Science Communications, HMP Communications, Impel, InteractiveForums, Keyquest, Krog and Partners, Lundbeck, M3 Global Research, Magnolia Innovation, MJH Holdings, Neurolief, Novartis, <i>P</i> Value Communications, Pain Insights, Inc, Palion Medical, Pulmatrix, Putnam Associates, SAI MedPartners, Satsuma, Slingshot Insights, Spherix Global Insights, Strategy Inc, System Analytic, Taylor and Francis, Teva, Theranica, Tremeau, Trinity Partners, Unity HA, XOC, and Zosano, salary from Dartmouth-Hitchcock Medical Center and Thomas Jefferson University, and.Continuing Medical Education (CME) honoraria from American Academy of Neurology, American Headache Society, Annenberg Center for Health Sciences, Catamount Medical Education, Diamond Headache Clinic, Forefront Collaborative, Haymarket Medical Education, Medical Education Speakers Network, Medical Learning Institute Peerview, Migraine Association of Ireland, Miller Medical Education, National Association for Continuing Education, North American Center for CME, The Ohio State University, Physicians’ Education Resource, PlatformQ Education, Primed, Texas Neurological Society, Vindico Medical Education, and WebMD/Medscape.G. L’Italien, is an employee and shareholder of Biohaven Pharmaceuticals.J. Cirillo, E. Kim, and J. M. Tweedie were employees and shareholders of Biohaven Pharmaceuticals at the time of study and manuscript completion. J. Cirillo and J. M. Tweedie are now employees of Pfizer.K. Lodaya, F. Pathan, and N. Antaki are employees of Boston Strategic Partners, Inc., which received funding to support the analysis and manuscript development from Biohaven Pharmaceuticals, which was acquired by Pfizer in October 2022.D. Riley was an employee of Boston Strategic Partners, Inc. at the time of this study.B. H. Nathanson’s company (OptiStatim, LLC) received a consulting fee for data analysis from Boston Strategic Partners, Inc.P. McAllister reports research support from Abbvie, Amgen, Biohaven, Lilly, Lundbeck and Teva, consultant/advisory boards for Abbvie, Biohaven, Impel, BDSI, ANI, Lilly, Teva and Lundbeck.